Kendra R. Adams
Principal Accounting Officer, CFO, Head of Corporate Affairs & TreasurerMs. Kendra R. Adams is Principal Accounting Officer of C4 Therapeutics, Inc. from May 15, 2026 and is Chief Financial Officer from September 18, 2023 and serves as its Treasurer September 2023 and is Head of Corporate Affairs. She served as Senior Vice President of Communications and Investor Relations at C4 Therapeutics, Inc., since November 2020 until September 18, 2023. She served as Vice President of External Communications and Investor Relations at Agios Pharmaceuticals, Inc and served as its Senior Director of Investor & Public Relations. She previously led investor relations at ARIAD Pharmaceuticals and began her investor relations career at Amgen. Ms. Adams began her professional career at General Electric, where she participated in the company’s intensive Financial Management Program. After GE, she joined KPMG LLP where she led consulting teams on a variety of financial and strategic matters. She holds a B.A. in Economics from Hamilton College.
Positions
- Company NameC4 Therapeutics, Inc.Stock CodeCCCCPositionPrincipal Accounting Officer, CFO, Head of Corporate Affairs & TreasurerColleagues
- AJAndrew J. HirschCEO, President & Director
- RHRonald H. W. CooperIndependent Chairman
- KCKenneth C. AndersonCo-Founder, Independent Director & Member of Scientific Advisory Board
- LMLeonard M. J. ReynoChief Medical Officer
- NSNathanael S. GrayCo-Founder & Member of Scientific Advisory Board
- UKUtpal KoppikarIndependent Director
